Use of probiotics in preterm neonate

Thomas Havranek, Mohamad Alhosni, Rita Chrivia

Research output: Chapter in Book/Report/Conference proceedingChapter


The gastrointestinal tract of a premature infant is characterized by abnormal bacterial colonization which has been linked to poorly developed intestinal immunity and upregulated intestinal inflammatory responses. Probiotic supplementation creates an exciting approach in modulating gastrointestinal development, potentially affecting intestinal and nonintestinal diseases. Majority of the clinical trials involving preterm neonates have evaluated the effect of probiotics on necrotizing enterocolitis, death, and eventually on feeding tolerance and growth. Less commonly on infectious complications/sepsis, neurodevelopment and immune function developments/responses have been measured. While the results of recent meta-analysis suggesting reduction of necrotizing enterocolitis and mortality due to probiotics administration are promising, the data at present time are insufficient to recommend routine probiotics use in preterm newborn population.

Original languageEnglish (US)
Title of host publicationDiet and Nutrition in Critical Care
PublisherSpringer New York
Number of pages9
ISBN (Electronic)9781461478362
ISBN (Print)9781461478379
StatePublished - Jan 1 2015

ASJC Scopus subject areas

  • General Medicine
  • General Biochemistry, Genetics and Molecular Biology


Dive into the research topics of 'Use of probiotics in preterm neonate'. Together they form a unique fingerprint.

Cite this